Literature DB >> 17309406

Opioid overdose deaths can occur in patients with naltrexone implants.

Amy E Gibson1, Louisa J Degenhardt, Wayne D Hall.   

Abstract

From Australian coronial records, we identified five deaths involving implantable naltrexone between 2000 and 2004. One man died from acute narcotism with a naltrexone implant in place and a blood naltrexone level of 0.3 mg/L. A woman died of combined drug effect (including naltrexone) accompanied by severe pain from a naltrexone implant site. These cases indicate that patients can die from opioid overdose with a naltrexone implant and blood naltrexone levels higher than reported blockade levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309406     DOI: 10.5694/j.1326-5377.2007.tb01126.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  14 in total

Review 1.  Clinical safety of 1500 mg oral naltrexone overdose.

Authors:  Albert Stuart Reece
Journal:  BMJ Case Rep       Date:  2010-09-07

2.  Advances in opioid antagonist treatment for opioid addiction.

Authors:  Walter Ling; Larissa Mooney; Li-Tzy Wu
Journal:  Psychiatr Clin North Am       Date:  2012-04-10

3.  Improved parameters of metabolic glycaemic and immune function and arterial stiffness with naltrexone implant therapy.

Authors:  Albert Stuart Reece
Journal:  BMJ Case Rep       Date:  2009-04-14

Review 4.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

5.  Provision of opioid substitution therapy services in Australian pharmacies.

Authors:  B B Chaar; J R Hanrahan; C Day
Journal:  Australas Med J       Date:  2011-04-30

6.  Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users.

Authors:  Christy K Scott; Michael L Dennis
Journal:  Addiction       Date:  2009-03-13       Impact factor: 6.526

Review 7.  Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.

Authors:  Nikolaj Kunøe; Philipp Lobmaier; Hanh Ngo; Gary Hulse
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

8.  Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management.

Authors:  Albert Stuart Reece
Journal:  Subst Abuse       Date:  2012-09-27

9.  Illicit opioid intoxication: diagnosis and treatment.

Authors:  A Fareed; S Stout; J Casarella; S Vayalapalli; J Cox; K Drexler
Journal:  Subst Abuse       Date:  2011-04-18

10.  Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Authors:  Paolo Mannelli; Kathleen S Peindl; Li-Tzy Wu
Journal:  Subst Abuse Rehabil       Date:  2011-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.